ThroughlineTM

From complexity to clarity, in one line.

I draw the clear, defensible path from what the science shows to where the market sees value: one continuous line, from signal to value, and the system to hold it under pressure.

Eric Shaffer  ·  Biopharma Commercial Architect

Commercial strategy and brand navigation

The point of view

More data. More AI. Less clarity.

Commercial teams have never had more data, more artificial intelligence (AI) output, or more velocity. What they have less of is clarity. The tools multiplied, but the line that connects signals to realized value still takes expert judgment, and that line is where value is won or lost.

Systems decide

Networks, provider groups, and payers now shape adoption through pathways, EMR defaults, and quality metrics, more than any single prescriber.

Networks amplify

Belief travels from experts to local champions to committee mentors faster than media reaches anyone.

Evidence convinces

What happens after launch outweighs the trial slide. Real-world proof has to travel and compound.

The advantage no longer belongs to whoever produces the most outputs. It belongs to whoever can model the outcome and draw the one clear line from signal to value, then hold it. That is what I build as a Commercial Architect: not more decks, but a decision system, where AI accelerates the synthesis and simulation, and I am accountable for the call at every gate. The standard is decision-grade: traceable, defensible, executable.

The method

DECALTM, the spine

An always-on commercial operating system. Five stages, one line. Each stage answers one question, does the work, runs a model, and leaves a decision-grade output. Each carries a single readiness gate, so confidence is engineered, not assumed. Lifecycle feeds back to Define, so the system never stops learning.

ALWAYS ON · LIFECYCLE FEEDS BACK TO DEFINE D E C A L
Select a stage above to explore its intent, engine, tools, and the pack you keep.

Frame the addressable opportunity through patient precision, and lock what is true before any strategy is built.

The engine

The Opportunity Modeler identifies where value concentrates.

Core tools

Truth Tester · Opportunity Zones · the Key Business Question (KBQ) Engine · the Readiness Diagnostic · the Truth Stack.

The pack you keep

Named, quantified cohorts · a first Value Equation and opportunity sizing · a prioritized KBQ learning plan that sets the cadence.

Translate cohort insight into stakeholder-specific truth, and pressure-test the value against cross-functional stakeholders.

The engine

The Confidence Calibrator tests how scenarios affect confidence.

Core tools

The Commercial Truth Pack; patient cohort modeling; the Value Equation; Quantifiable Value + Access Propositions (QVAPs); scenario modeling and synthetic responders.

The pack you keep

A validated Value Equation · a belief-behavior map and proof-gap log · the first QVAP library, with net present value (NPV) and feasibility bands.

Turn validated value into a differentiated, evidence-backed narrative built to change belief and behavior.

The engine

The Commercial Sequencer builds and prioritizes the playbook.

Core tools

Brand Role · the Value Hierarchy · the Proof Ladder · Architecture Guardrails · Segment Emphasis Rules · Positioning.

The pack you keep

A refined QVAP library · a Prioritized Message Flow and Mind-Shift Roadmap · positioning and a modular content plan.

Translate strategy into action, the value tools and access simulation that turn a value story into coverage and adoption.

The engine

The Go-to-Market (GTM) Orchestrator connects stakeholders to one value path.

Core tools

Signature Programs · the Moment Map · Personalization Rules · the Modular Content and Engagement System · Experience Instrumentation.

The pack you keep

Modular content and an engagement system; value-demonstration tools and the Value Analyzer; a systems-access program; Key Performance Indicator (KPI) and data-gap architecture with a source-of-truth dashboard.

Make proof travel and compound, turning continuous learning into a governed rhythm rather than an annual scramble.

The engine

The Lifecycle Navigator extends value beyond launch.

Core tools

Brand and competitor clinical development programs; new indications and cohorts; real-world evidence (RWE) needs; access conditions; performance measures and learning loops.

The pack you keep

A lifecycle roadmap linking clinical milestones, evidence generation, market changes and future opportunities to the actions that must start now. Priorities, dependencies and refresh triggers connect the 1/3/5/10-year view back to Define.

The value architecture

The value equation I design

Brand Value Future-state simulations

Future-state simulations model Brand Value

+WHO(Patient Cohorts)+WHAT(Unmet Needs)+WHEN(Journey + Lifecycle)+WHY(Differentiation)

WHERE makes care setting, market and access context explicit.

CaVA™, Commercial Value Architecture, keeps the value coherent across DECAL. I connect patient and stakeholder needs to evidence, differentiation and access, then test the choices through scenarios.

A Quantifiable Value + Access Proposition (QVAP) makes the value and its proof requirements explicit. The architecture carries that logic into the commercial plan and lifecycle.

Modeled, not guessed

I simulate the market before you spend in it

The methodology produces models and math, not just frameworks. Each is named, produces a specific output, and is tiered honestly, so the level of precision is clear.

Patient Cohort Modeling

Ranks cohorts by volume, unmet need, differentiation, and access readiness to find the invest-to-win populations, and scales to a ten-dimension scorecard at portfolio level.

Archetype Segmentation

Bundles patients, HCPs, and systems and payers into connected, value-based segments. The whole decision chain is targeted as one, not in silos.

Synthetic Responder Lab

Simulates how payers, healthcare professionals (HCPs) and patients react to a value story and its QVAPs before a dollar is spent. Produces a Value Driver Impact Scorecard, friction heatmap, and scenario deltas, and flags equity risk.

Value + Access Scoring

The "what would it take to say yes" simulation. Scores each value claim against the payers and health systems that decide on coverage, from high-confidence to dealbreaker.

Opportunity to Value Simulation

Turns opportunity into field-force, investment, uptake bands, ROI ranges, and multi-year NPV with sensitivity analysis, from single-option to bundled to portfolio.

The Throughline Simulator

A full DECAL-aligned commercialization and access simulation, end to end: a cohort-based Value Equation, scenario stacks with net present value (NPV) and feasibility bands, a modular GTM kit synced to evidence, and a living lifecycle and evidence plan.

Data-RichHybridHuman-DrivenThe Living Lab: testing and execution reinforce each other
How an engagement runs

Built with you, not for you

The system is co-created with your team, not delivered to one. Every workshop closes in a Decision Lock, and Signal Checks keep the line current between them.

Workshops decide

Facilitated working sessions where your team co-creates and the truth gets decided. Each runs Pre, Live, and Post, and emits an inheritable output the next stage builds on.

Signal Checks build confidence

Lighter, AI-accelerated reads that sharpen a workshop before, during, and after, keeping the line current as the market moves.

Decision Lock

Each lock records what was decided, who owns it, the confidence level, and the signals that would reopen it.

Choose a workshop to see the question, working session and outputs:

The cadence

A build runs three evidence-gated phases, Discover, Validate, and Form: only what proves out advances, and scope locks at the first gate. Then the line runs a repeating 90-day cadence, re-entering the loop with higher certainty each pass. The method repeats across any brand: concentrate, validate, compound.

What you walk away with

Cohort Cards + opportunity mapValidated Value EquationQVAP libraryMessaging architecture + PMFValue Analyzer + access toolsSystems-access program1/3/5/10-year roadmap

Every artifact is traceable to evidence and governance, and built to keep working after the engagement ends.

The governed engine

CHART connects the work. From prompts to proof.

CHART is my governed operating model for connecting inquiry, evidence, modeling and production. I assign the roles and tools each task needs, with clear human review and decision ownership. Sources and key business questions stay connected to the work from intake through lifecycle.

CHART ORCHESTRATOR GOVERNED AI Value Analyzer KBQ Librarian Cohort Architect Value Builder QVAP Designer Responder Simulator Roadmap Developer Value Orchestrator Lifecycle Navigator GUARDRAILS · EDITOR · FACT-CHECK · COMPLIANCE
The closed loop

The roles connect research, cohort understanding, value, modeling, planning and lifecycle learning. I bring in the functions the assignment needs.

The guardrails

Editorial, evidence and relevant qualified review support the work. Missing proof becomes an explicit gap, with an owner and a consequence for the decision.

Governed production

I connect the brief, sources, decisions and delivery through defined handoffs and quality checks. Learning from the work updates the methods and the next brief.

Throughline in practice

See the system working

SignalThroughline lens into systemSystemDecision

See how a signal
becomes a decision

Follow one commercial question through four short steps: the signals, the workshop, the choice and the output.

27 inputsThroughline lens into journeyJourneyPriorities

27 inputs.
One connected journey.

Follow one case through four short chapters. See how the evidence connects, what emerged and the decisions it prepared.

How to start

Entry points scale to the moment

Diagnose

Rapid Value Diagnostic

A one-page read where every line ties to a business question, a stage, and an owner. Easy entry, full system.

Activate

Momentum Builder

Pressure-tests the plays and advances only the ones that survive, into validated action.

Sustain

Lifecycle Navigator

Rolls scenarios into a 3/5/10-year roadmap so the proof compounds year over year.

The system in depth

Three ways to go deeper

The product set

One system. Many engines.

Throughline is the operating system I built and operate. Its connected engines turn great work into a repeatable one.

Value and access

I work where decisions are made

The value equation sits at the center, and every stakeholder is evaluated against it, with a focus on securing value and access before the creative begins.

The method, documented

A playbook behind every play

The system is written down. Each play has a documented playbook with inputs, exercises, outputs, and refresh logic, so the work is repeatable, auditable, and built to travel.

Value and access · I work where decisions are made

The value equation sits at the center, and every stakeholder is evaluated against it, with a specific focus on securing value and access. Integrated delivery networks and provider groups do not buy the way payers do; Throughline maps the winnable pockets inside highly contracted markets, then wins them with a system-access program built in the right order.

Clinical confidence first

Evidence bundles, pathway insertion, and objection libraries, because clinical confidence has to be secured before operational or economic value is heard.

Operational integration

Electronic medical record (EMR) order-set builds, coding and throughput support. Decisions are made by committees but enforced by staff, so the work reaches the frontline.

Patient navigation

Switch-stability, first-fill assurance, and continuity, with value framed as total cost of care, not discount depth.

The access question: what would it take to say yes?

The Value + Access Scoring simulation scores each value claim against the people who decide on coverage and access, payers and health systems alike, on six named criteria, from high-confidence to dealbreaker, and names the levers that move a no to a yes.

  • Clinical differentiationMeaningful improvement versus standard of care.
  • Population clarity + restriction riskHow definable and targetable the population is.
  • Budget impact + affordabilityCost per treated patient, offsets, persistence.
  • Quality-metric alignmentFit to the measures payers are graded on.
  • Real-world-data readinessEvidence beyond the trial, and willingness to contract on it.
  • Perceived behavioral riskReliance on standard of care, prior-authorization complexity, provider resistance.

A compliant pre-approval and post-approval value package shares one Value Equation, one cohort set, and one budget-impact model, so most of the value-and-access story is built before approval and refreshed on a cadence.

The product set · one system, many engines

Value Equation + Commercial Truth Pack

A portable, proof-linked statement of who to grow with, why the brand wins, and what must be proven. The north star that makes strategy investable before activation begins.

The Simulation Suite

The Commercial Modeler (quantifies opportunity, the lift required, and what it is worth) plus the CaVA simulations across the five stages.

The Commercial Accelerator

Turns friction into prioritized action: barriers to neutralize, drivers to motivate, levers to build, tested against synthetic stakeholders and handed off as validated action briefs. Investable, not inspirational.

The Living Lab

A closed-loop environment where testing and execution reinforce each other, converting experiments into reusable, governed inputs.

The CHART Agent Suite

The specialist roles and operating instructions that support research, strategy, modeling and delivery, with defined human review and decisions.

Continuity

Keeps sources, decisions and learning connected, so the next decision can build on what is already known.

The method, documented · a playbook behind every play
The operating system, and how to run it

CaVA Simulation Playbook

the full DECAL-aligned commercialization and access simulation journey.

Learning Plan Innovation Playbook

defines the KBQs, the data gaps, and the continuous learning loops.

Commercial Development Playbook

builds an integrated strategic blueprint, the strategic imperatives, and a commercial roadmap.

The core method that shapes the work

Patient Cohort Simulation Playbook

cohort definition, journey, and opportunity modeling.

QVAP and Value Analyzer Playbooks

message architecture, value narratives, and the tools that carry them.

Modular Content and Tactic Developer Playbook

converts strategy into modular, channel-ready tactics that localize without drift.

The market-facing context

GTM Playbook

go-to-market plans that turn proof into confident adoption.

Data and RWE Gap Playbook

maps the evidence gaps, prioritizes the real-world evidence and health economics and outcomes research (HEOR) needs, sequences an evidence-generation plan.

Lifecycle Innovation Playbook

simulations, Opportunity to Value modeling, and a roadmap with trigger logic.

The playbooks are the depth behind the offering, not separate products. One method, written down, so the proof travels.

Let's define your Throughline

Connect to co-create it, or to talk through an upcoming strategic need.

eshafferhcs@gmail.com·Eric Shaffer, Biopharma Commercial Architect

Throughline experience